Jung In Sub, Shin Cheol Min, Park Sung Jae, Park Young Soo, Yoon Hyuk, Jo Hyun Jin, Kim Nayoung, Lee Dong Ho
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Department of Health Promotion Center, Seoul National University Bundang Hospital, Seongnam, Korea.
Intest Res. 2019 Jul;17(3):404-412. doi: 10.5217/ir.2018.00072. Epub 2018 Nov 12.
BACKGROUND/AIMS: To examine whether visceral adiposity serves as a risk factor for colorectal cancer (CRC) and colorectal adenomas.
Two hundred healthy subjects, 200 patients with colorectal adenoma, and 151 patients with CRC (46 with early-stage and 105 with advanced-stage cancers) were enrolled at a tertiary referral hospital. All subjects underwent colonoscopy, and had laboratory data, and computed tomography (CT) scan available for abdominal fat measurement. An abdominal CT scan taken 1 to 4 years (mean interval, 20.6 months) before the diagnosis of CRC was also available in the 42 CRC patients.
The mean areas of visceral adipose tissue (VAT) areas in the control, adenoma, early- and advanced-stage CRC groups were 94.6, 116.8, 110.4, and 99.7 cm2 , respectively (P<0.001). The risk of adenoma positively correlated with VAT area and the visceral-to-total fat ratio (P for trend <0.01), but the risk of CRC did not (P>0.05). The risk of both adenoma and CRC positively correlated with fasting plasma glucose levels (P for trend <0.05). In patients with early-stage cancer (n=17), VAT area decreased when the CT scan at diagnosis was compared with that taken before the diagnosis of CRC, but superficial adipose tissue area did not, so visceral-to-total fat ratio significantly decreased (46.6% vs. 50.7%, respectively, P=0.018).
VAT area is related to the risk of colorectal adenoma. However, VAT decreases from the early stages of CRC. Impaired fasting glucose has a role in colorectal carcinogenesis.
背景/目的:探讨内脏脂肪是否为结直肠癌(CRC)及结直肠腺瘤的危险因素。
在一家三级转诊医院招募了200名健康受试者、200名结直肠腺瘤患者和151名CRC患者(46例早期癌和105例晚期癌)。所有受试者均接受结肠镜检查,并获取实验室数据以及用于腹部脂肪测量的计算机断层扫描(CT)。42例CRC患者还可获取在CRC诊断前1至4年(平均间隔20.6个月)进行的腹部CT扫描。
对照组、腺瘤组、早期和晚期CRC组的内脏脂肪组织(VAT)平均面积分别为94.6、116.8、110.4和99.7 cm²(P<0.001)。腺瘤风险与VAT面积及内脏脂肪与总脂肪之比呈正相关(趋势P<0.01),但CRC风险则不然(P>0.05)。腺瘤和CRC风险均与空腹血糖水平呈正相关(趋势P<0.05)。在早期癌症患者(n = 17)中,将诊断时的CT扫描与CRC诊断前的扫描相比,VAT面积减小,但浅表脂肪组织面积未减小,因此内脏脂肪与总脂肪之比显著降低(分别为46.6%对50.7%,P = 0.018)。
VAT面积与结直肠腺瘤风险相关。然而,VAT在CRC早期阶段会减小。空腹血糖受损在结直肠癌发生过程中起作用。